Biogen Portugal Sociedade Farmaceutica Unipessoal Lda. secures contract for Acquisition Of Natalizumab 150 Mg/Ml Sol Inj Ser 1 Ml Sc And Noradrenaline 1 Mg/Ml Sol Inj Fr 10 Ml Iv

Portugal, Sept. 11 -- Portugal based Biogen Portugal Sociedade Farmaceutica Unipessoal Lda. has secured contract from Unidade Local De Saude De Sao Jose, E. P. E. for Acquisition Of Natalizumab 150 Mg/Ml Sol Inj Ser 1 Ml Sc And Noradrenaline 1 Mg/Ml Sol Inj Fr 10 Ml Iv. The value of the contract is worth 1806000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....